Orchard Therapeutics (ORTX)
NASDAQ: ORTX
· Real-Time Price · USD
16.70
0.05 (0.30%)
At close: Jan 23, 2024, 10:00 PM
Orchard Therapeutics Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -35.32M | -12.31M | -17.41M | -7.88M | -47.56M | -50.92M | -44.3M | -36.35M | -36.45M | -36.61M | -35.18M |
Depreciation & Amortization | 652K | 655K | 643K | 721K | 654K | 657K | 709K | 676K | 648K | 508K | 495K |
Stock-Based Compensation | 2.47M | 2.58M | 3.51M | 3.93M | 3.47M | 3.96M | 4.66M | 5.34M | 5.39M | 5.54M | 6.27M |
Other Working Capital | -1.61M | -86K | -6.66M | 17.93M | -12.18M | 1.36M | 11.45M | -603K | 247.22M | 263.24M | 279.94M |
Other Non-Cash Items | 11.47M | -12.68M | -10.52M | -23.28M | 23.41M | 18.41M | 5.99M | -282K | -7.56M | 4.89M | 2.97M |
Deferred Income Tax | 677K | 206K | 242K | -5.6M | n/a | n/a | 787K | 373K | 11.35M | 393K | -446K |
Change in Working Capital | -3.84M | -6.29M | -5.97M | 20.04M | 2.1M | 1.51M | 12.55M | -3.15M | 10.21M | -10.77M | -13.35M |
Operating Cash Flow | -23.89M | -27.83M | -29.51M | -12.08M | -17.93M | -26.38M | -19.6M | -33.4M | -16.41M | -36.05M | -39.24M |
Capital Expenditures | -126K | 31K | -514K | -484K | -4.46M | -1.17M | -398K | -393K | -1.91M | -596K | -339K |
Cash Acquisitions | -11.71M | 26.72M | 8.83M | n/a | -51.83M | n/a | n/a | 887K | 887K | n/a | n/a |
Purchase of Investments | -32.12M | -75.72M | -38.83M | -41.08M | -20.32M | -21.21M | -29.68M | -21.56M | -75.35M | -36.58M | -130.39M |
Sales Maturities Of Investments | 43.82M | 49M | 30M | 32.03M | 72.15M | 42.03M | 55.19M | 36.72M | 64.5M | 86.31M | 47.2M |
Other Investing Acitivies | 11.71M | -26.72M | -8.83M | 7.97M | 51.83M | n/a | n/a | -887K | -870K | 199K | n/a |
Investing Cash Flow | 11.58M | -26.69M | -9.35M | -1.56M | 47.37M | 19.64M | 25.11M | 14.76M | -12.74M | 49.34M | -83.53M |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | -13K | -877K | -12K | -19K | -19K | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | -2.35M | 30.93M | 31.51M | -811K | -19K | 137K | n/a | 150K | 4.06M | 7.42M | 146.43M |
Financial Cash Flow | -2.35M | 30.93M | 31.51M | -811K | -19K | 137K | n/a | 150K | 4.06M | 7.42M | 146.43M |
Net Cash Flow | -14.8M | -23.21M | -6.94M | -12.38M | 27.28M | -7.3M | 4.86M | -18.41M | -25.61M | 21.05M | 23.75M |
Free Cash Flow | -24.02M | -27.8M | -30.02M | -12.57M | -22.39M | -27.55M | -20M | -33.79M | -18.31M | -36.65M | -39.58M |